Stephen P. MacMillan
Net Worth

Last updated:

What is Stephen P. MacMillan net worth?

The estimated net worth of Mr. Stephen P. MacMillan is at least $147,646,900 as of 30 Jul 2024. He owns shares worth $78,274,342 as insider, has earned $17,012,558 from insider trading and has received compensation worth at least $52,360,000 in Hologic, Inc..

What is the salary of Stephen P. MacMillan?

Mr. Stephen P. MacMillan salary is $4,760,000 per year as Chairman, Chief Executive Officer & Pres in Hologic, Inc..

How old is Stephen P. MacMillan?

Mr. Stephen P. MacMillan is 61 years old, born in 1964.

What stocks does Stephen P. MacMillan currently own?

As insider, Mr. Stephen P. MacMillan owns shares in one company:

Company Title Shares Price per share Total value
Hologic, Inc. (HOLX) Chairman, Chief Executive Officer & Pres 1,157,562 $67.62 $78,274,342

What does Hologic, Inc. do?

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX logo
HOLX
Hologic, Inc.
$67.62

Stephen P. MacMillan insider trading

Hologic, Inc.

Mr. Stephen P. MacMillan has made 13 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 7,634 units of HOLX stock worth $615,300 on 30 Jul 2024.

The largest trade he's ever made was exercising 355,427 units of HOLX stock on 6 Dec 2016. As of 30 Jul 2024 he still owns at least 1,157,562 units of HOLX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,634 $80.6 $615,300
Option
Non-qualified Stock Option (Right to Buy) 44,039 $26.21 $1,154,262
Option
Common Stock 44,039 $26.21 $1,154,262
Sale
Common Stock 20,228 $82.32 $1,665,169
Sale
Common Stock 16,177 $81.44 $1,317,455
Option
Non-qualified Stock Option (Right to Buy) 3,672 $26.21 $96,243
Sale
Common Stock 3,672 $80.13 $294,223
Option
Common Stock 3,672 $26.21 $96,243
Option
Common Stock 47,711 $26.21 $1,250,505
Sale
Common Stock 47,711 $70.41 $3,359,188
Option
Non-qualified Stock Option (Right to Buy) 47,711 $26.21 $1,250,505
Sale
Common Stock 12,501 $76.02 $950,326
Sale
Common Stock 20,999 $75.43 $1,584,039
Sale
Common Stock 52,529 $75.57 $3,969,564
Option
Non-qualified Stock Option (Right to Buy) 95,422 $26.21 $2,501,011
Sale
Common Stock 42,893 $75.94 $3,257,294
Option
Common Stock 95,422 $26.21 $2,501,011
Option
Non-qualified Stock Option (Right to Buy) 215,996 N/A N/A
Option
Common Stock 215,996 N/A N/A
Sale
Common Stock 190,996 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 215,996 N/A N/A
Sale
Common Stock 194,396 N/A N/A
Option
Common Stock 215,996 N/A N/A
Sale
Common Stock 194,396 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 215,996 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 215,996 $22.29 $4,814,551
Option
Common Stock 215,996 N/A N/A
Sale
Common Stock 194,396 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 215,996 N/A N/A
Option
Common Stock 215,996 N/A N/A
Option
Common Stock 17,348 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 17,348 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 15,119 N/A N/A
Option
Common Stock 15,119 N/A N/A
Option
Common Stock 47,668 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 19,628 N/A N/A
Option
Common Stock 294,912 N/A N/A
Option
Performance Stock Unit Award (Right to Receive) 277,564 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 17,348 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 15,119 N/A N/A
Option
Common Stock 15,119 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 237,500 N/A N/A
Option
Common Stock 237,500 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 47,667 N/A N/A
Option
Common Stock 355,427 N/A N/A
Option
Performance Stock Unit Award (Right to Receive) 307,760 N/A N/A
Option
Common Stock 17,348 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 17,348 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 15,119 N/A N/A
Option
Common Stock 15,119 N/A N/A
Option
Common Stock 47,668 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 47,668 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 17,347 N/A N/A
Option
Common Stock 17,347 N/A N/A
Option
Common Stock 43,221 $31.85 $1,376,589
Option
Performance Stock Unit Award ((MP) Right to Receive) 43,221 $31.85 $1,376,589
Option
Common Stock 43,221 $29.61 $1,279,774
Option
Performance Stock Unit Award ((MP) Right to Receive) 43,221 $29.61 $1,279,774
Option
Restricted Stock Unit Award (Right To Receive) 47,666 $26.56 $1,265,771
Option
Common Stock 47,666 $26.56 $1,265,771
Option
Performance Stock Unit Award ((MP) Right to Receive) 43,220 $25.33 $1,094,763
Option
Common Stock 43,220 $25.33 $1,094,763
Purchase
Common Stock 37,100 $21.6 $801,360
Purchase
Common Stock 1,500 $20.98 $31,470
Purchase
Common Stock 107,816 $20.81 $2,243,651
Purchase
Common Stock 91,084 $20.75 $1,889,993

Hologic key executives

Hologic, Inc. executives and other stock owners filed with the SEC: